AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19707579 — intervention group
Group type: COMPARATOR
Intervention: Bar graph of average duration of symptoms
Number of subjects: 1760
Study 19707579 — intervention group
Group type: COMPARATOR
Intervention: Bar graph of proportion with symptoms on both days three and seven
Number of subjects: 1760
Study 17314584 — intervention group
Group type: EXPERIMENTAL
Intervention: Valdecoxib 40 mg q.d. (with a second dose on day 1)
Number of subjects: 340
Study 17314584 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac 75 mg b.i.d.
Number of subjects: 340
Study 17314584 — intervention group
Group type: EXPERIMENTAL
Intervention: Valdecoxib
Number of subjects: 340
Study 17314584 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 340
Study 15357650 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg of lamivudine daily
Number of subjects: 10
Study 15357650 — intervention group
Group type: COMPARATOR
Intervention: 100 mg of lamivudine daily
Number of subjects: 10
Study 11430394 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 200
Study 11430394 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 200
Study 11430394 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine
Number of subjects: 200
Study 11430394 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 200
Study 9743085 — intervention group
Group type: EXPERIMENTAL
Intervention: Uvulopalatopharyngoplasty
Number of subjects: 62
Study 9743085 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser palatoplasty
Number of subjects: 62
Study 9743085 — intervention group
Group type: EXPERIMENTAL
Intervention: Diathermy palatoplasty
Number of subjects: 62
Study 9743085 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 62
Study 7849144 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 600 mg/day for 6 months
Number of subjects: 36
Study 7849144 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 36
Study 3381712 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen (1 mg twice daily for 3 months)
Number of subjects: 75
Study 3381712 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen (1 mg twice daily for 5 months)
Number of subjects: 75
Study 3381712 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5 months)
Number of subjects: 75
Study 3381712 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen (5 months)
Number of subjects: 75
Study 29982583 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC) 0.4 to 0.6 mg/kg body weight
Number of subjects: 47
Study 28818031 — intervention group
Group type: EXPERIMENTAL
Intervention: Danggui Buxue Decoction (DBD)
Number of subjects: 89
Study 28818031 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 89
Study 24978159 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep problems at baseline (43% reported sleep problems, n = 215)
Number of subjects: 499
Study 24978159 — intervention group
Group type: COMPARATOR
Intervention: No sleep problems at baseline (57% did not report sleep problems, n = 284)
Number of subjects: 499
Study 24978159 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued sleep problems
Number of subjects: 499
Study 23153942 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous irrigation with an outflow of water (group 3)
Number of subjects: 36
Study 23153942 — intervention group
Group type: COMPARATOR
Intervention: Continuous irrigation without an outflow of water (group 2)
Number of subjects: 36
Study 23153942 — intervention group
Group type: COMPARATOR
Intervention: No irrigation (group 1)
Number of subjects: 36
Study 23153942 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible cystoscopy with NCIS
Number of subjects: 36
Study 23153942 — intervention group
Group type: COMPARATOR
Intervention: Flexible cystoscopy without NCIS
Number of subjects: 36
Study 22052306 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiplexed 1,440 and 1,320 nm fractionated laser treatment
Number of subjects: 20
Study 20225467 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioned for 7 days at 37 degrees C in 75% ethanol aqueous solution
Number of subjects: 36
Study 20225467 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersed in fluoride gel (Elmex Gelée) at 37 degrees C for 1 hour
Number of subjects: 36
Study 20225467 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated toothbrushing with an electric toothbrush while being immersed in toothpaste
Number of subjects: 36
Study 17036705 — intervention group
Group type: EXPERIMENTAL
Intervention: Crest Dual Action Whitening Toothpaste
Number of subjects: 24
Study 17036705 — intervention group
Group type: COMPARATOR
Intervention: Control anti-caries dentifrice
Number of subjects: 24
Study 14607663 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg morphine
Number of subjects: 40
Study 14607663 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg anisodamine
Number of subjects: 40
Study 14607663 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 mg atropine
Number of subjects: 40
Study 14607663 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg buscopan
Number of subjects: 40
Study 14607663 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 10695694 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention addressing consistent condom use, reducing alcohol consumption, brothel patronage, and improving sexual negotiation and condom skills.
Number of subjects: 450
Study 10695694 — intervention group
Group type: COMPARATOR
Intervention: Control group (distant camps)
Number of subjects: 450
Study 10695694 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 450
Study 9502522 — intervention group
Group type: EXPERIMENTAL
Intervention: Injured soldiers (30 with permanent disabling injuries)
Number of subjects: 90
Study 9502522 — intervention group
Group type: EXPERIMENTAL
Intervention: Injured soldiers (30 with nondisabling injuries)
Number of subjects: 90
Study 9502522 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninjured soldiers
Number of subjects: 90
Study 9502522 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 90
Study 8384952 — intervention group
Group type: EXPERIMENTAL
Intervention: Local nervous blockade with bupivacaine (5 mg/ml) subcutaneously injected (15 ml)
Number of subjects: 10
Study 8384952 — intervention group
Group type: COMPARATOR
Intervention: Control experiments without local nervous blockade
Number of subjects: 10
Study 8384952 — intervention group
Group type: EXPERIMENTAL
Intervention: Local nervous blockade with bupivacaine
Number of subjects: 10
Study 3529000 — intervention group
Group type: EXPERIMENTAL
Intervention: labetalol 400 mg/day
Number of subjects: 30
Study 3529000 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study 31218636 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure treatment (systolic BP target: 110‐139 mmHg)
Number of subjects: 195
Study 31218636 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure treatment (systolic BP target: 140‐179 mmHg)
Number of subjects: 195
Study 30538533 — intervention group
Group type: EXPERIMENTAL
Intervention: Interspinous process decompression (IPD) with the Superion Indirect Decompression System
Number of subjects: 190
Study 30538533 — intervention group
Group type: EXPERIMENTAL
Intervention: Interspinous process decompression (IPD)
Number of subjects: 190
Study 27549354 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat meal (low viscosity, 0.042 Pa s)
Number of subjects: 10
Study 27549354 — intervention group
Group type: EXPERIMENTAL
Intervention: Oatmeal (high viscosity, 0.266 Pa s)
Number of subjects: 10
Study 27549354 — intervention group
Group type: EXPERIMENTAL
Intervention: High nutrient wheat meal
Number of subjects: 10
Study 24185211 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 100
Study 24185211 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 100
Study 22863164 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and sauna
Number of subjects: 16
Study 22863164 — intervention group
Group type: EXPERIMENTAL
Intervention: Sauna alone
Number of subjects: 16
Study 22863164 — intervention group
Group type: COMPARATOR
Intervention: Control period
Number of subjects: 16
Study 20347840 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy (20-minute session between postoperative days 2 and 5)
Number of subjects: 58
Study 20347840 — intervention group
Group type: COMPARATOR
Intervention: Standard care (20-minute quiet time between postoperative days 2 and 5)
Number of subjects: 58
Study 18366572 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated pegboard (APB 2000) test for unimpaired participants performing normally
Number of subjects: 21
Study 18366572 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated pegboard (APB 2000) test for individuals with shoulder pain
Number of subjects: 21
Study 18366572 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated pegboard (APB 2000) test for unimpaired participants feigning shoulder pain
Number of subjects: 21
Study 15840102 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulphate (SLS) 1% cm(‐2) applied twice daily for 4 days
Number of subjects: 32
Study 15840102 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulphate (SLS) 0.5% cm(‐2) applied twice daily for 4 days
Number of subjects: 32
Study 15840102 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of cold and SLS (SLS 1% or 0.5%) applied twice daily for 4 days
Number of subjects: 32
Study 15840102 — intervention group
Group type: COMPARATOR
Intervention: Cold exposure alone (4 degrees C for 90 s or 15 degrees C for 10 min)
Number of subjects: 32
Study 12416768 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine treatment (0.12% local irrigation and gel)
Number of subjects: 16
Study 12416768 — intervention group
Group type: COMPARATOR
Intervention: Mechanical cleansing and oral hygiene instructions (Control group)
Number of subjects: 16
Study 12416768 — intervention group
Group type: COMPARATOR
Intervention: Mechanical cleansing alone
Number of subjects: 16
Study 12416768 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical debridement supplemented with chlorhexidine
Number of subjects: 16
Study 10484800 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportional Assist (PA)
Number of subjects: 36
Study 10484800 — intervention group
Group type: COMPARATOR
Intervention: Assist/Control (A/C)
Number of subjects: 36
Study 10484800 — intervention group
Group type: COMPARATOR
Intervention: Intermittent Mandatory Ventilation (IMV)
Number of subjects: 36
Study 9177613 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestin-estrogen therapy (group I, 96 patients)
Number of subjects: 180
Study 9177613 — intervention group
Group type: COMPARATOR
Intervention: Antihypertensive drugs (group II, 84 patients)
Number of subjects: 180
Study 9177613 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestin-estrogen therapy (for 23 unresponsive patients from group II)
Number of subjects: 180
Study 1726458 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine, OKT3, and Euro-Collins preservation period (January 1984 to September 1987)
Number of subjects: 2090
Study 1726458 — intervention group
Group type: EXPERIMENTAL
Intervention: University of Wisconsin solution preservation period (October 1987 to December 1988)
Number of subjects: 2090
Study 1726458 — intervention group
Group type: EXPERIMENTAL
Intervention: FK506 period (January 1989 to December 1990)
Number of subjects: 2090
Study 1726458 — intervention group
Group type: COMPARATOR
Intervention: Patients in critical condition
Number of subjects: 2090
Study 6275829 — intervention group
Group type: EXPERIMENTAL
Intervention: Naturally occurring dietary fibre (salad vegetables and apple)
Number of subjects: 25
Study 6275829 — intervention group
Group type: COMPARATOR
Intervention: Simple sugars and starch added to a gelatine and cream cheese base (control)
Number of subjects: 25
Study 31107412 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Affect Induction (watching movie clips for 15 mins)
Number of subjects: 147
Study 31107412 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral Affect Induction (watching movie clips for 15 mins)
Number of subjects: 147
Study 28093466 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan 200 mg
Number of subjects: 454
Study 28093466 — intervention group
Group type: COMPARATOR
Intervention: Olmesartan 20 mg
Number of subjects: 454
Study 28093466 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 454
Study 25887580 — intervention group
Group type: EXPERIMENTAL
Intervention: Short colonic reservoir (observation group)
Number of subjects: 81
Study 25887580 — intervention group
Group type: COMPARATOR
Intervention: Long colonic reservoir (control group)
Number of subjects: 81
Study 23186035 — intervention group
Group type: EXPERIMENTAL
Intervention: GEn 1,200 mg/day
Number of subjects: 421
Study 23186035 — intervention group
Group type: EXPERIMENTAL
Intervention: GEn 2,400 mg/day
Number of subjects: 421
Study 23186035 — intervention group
Group type: EXPERIMENTAL
Intervention: GEn 3,600 mg/day
Number of subjects: 421
Study 23186035 — intervention group
Group type: COMPARATOR
Intervention: PGB 300 mg/day
Number of subjects: 421
Study 23186035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 421
Study 21092934 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavior therapy (CBT) for IBS based on exposure and mindfulness exercises
Number of subjects: 75
Study 19696680 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum
Number of subjects: 20
Study 19696680 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-down positioning
Number of subjects: 20
Study 17137560 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐MPH‐ER 20 mg
Number of subjects: 221
Study 17137560 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐MPH‐ER 30 mg
Number of subjects: 221
Study 17137560 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐MPH‐ER 40 mg
Number of subjects: 221
Study 17137560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study 17137560 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐MPH‐ER (all doses)
Number of subjects: 221
Study 15102869 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg dose of montelukast oral granules
Number of subjects: 32
Study 15102869 — intervention group
Group type: COMPARATOR
Intervention: 10 mg film-coated tablet (FCT) in adults
Number of subjects: 32
Study 12234056 — intervention group
Group type: EXPERIMENTAL
Intervention: DOMS exercise
Number of subjects: 0
Study 12234056 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline injection (5 x 200 microl 5.8% NaCl)
Number of subjects: 0
Study 12234056 — intervention group
Group type: COMPARATOR
Intervention: Control leg (no treatment)
Number of subjects: 0
Study 12234056 — intervention group
Group type: COMPARATOR
Intervention: Normal saline injection
Number of subjects: 0
Study 9661616 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (1,000 micrograms/day, every 12 hours for 14 days)
Number of subjects: 25
Study 9661616 — intervention group
Group type: COMPARATOR
Intervention: Placebo inhaler
Number of subjects: 25
Study 7621734 — intervention group
Group type: EXPERIMENTAL
Intervention: Telecommunication system for outpatient management, self-monitoring blood glucose data transmitted by modem every 2 weeks, reviewed by nurse practitioners
Number of subjects: 106
Study 7621734 — intervention group
Group type: COMPARATOR
Intervention: Standard care with regimen adjustments made by physicians
Number of subjects: 106
Study 7621734 — intervention group
Group type: EXPERIMENTAL
Intervention: Telecommunication system for outpatient management
Number of subjects: 106
Study 2651567 — intervention group
Group type: EXPERIMENTAL
Intervention: Low/slow bromocriptine regimen (maximum 25 mg/day)
Number of subjects: 134
Study 2651567 — intervention group
Group type: EXPERIMENTAL
Intervention: High/fast bromocriptine regimen (maximum 100 mg/day)
Number of subjects: 134
Study 2651567 — intervention group
Group type: EXPERIMENTAL
Intervention: Low/slow bromocriptine regimen
Number of subjects: 134
Study 2651567 — intervention group
Group type: EXPERIMENTAL
Intervention: High/fast bromocriptine regimen
Number of subjects: 134
Study 175693 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with radiation therapy and 5-Fluorouracil
Number of subjects: 136
Study 175693 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy alone
Number of subjects: 136
Study 31375426 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble fibre (inulin 12 g/day)
Number of subjects: 17
Study 31375426 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble fibre + probiotic (inulin 12 g/day + multi-strain probiotic >25 billion CFU)
Number of subjects: 17
Study 31375426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 29466222 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical algorithm (individual patient characteristics)
Number of subjects: 60
Study 29466222 — intervention group
Group type: COMPARATOR
Intervention: Standard method
Number of subjects: 60
Study 24337896 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth iodoform paraffin paste pack
Number of subjects: 32
Study 24337896 — intervention group
Group type: COMPARATOR
Intervention: No ear pack
Number of subjects: 32
Study 24516951 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg oral lincomycin + high fiber (L + F)
Number of subjects: 0
Study 24516951 — intervention group
Group type: COMPARATOR
Intervention: Placebo + high fiber (P + F)
Number of subjects: 0
Study 22282954 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of clopidogrel 75 mg
Number of subjects: 24
Study 22282954 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation of clopidogrel 75 mg
Number of subjects: 24
Study 20055193 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.7 microg x kg(‐1) x hr(‐1) after a bolus infusion at 6.0 microg x kg(‐1) x hr(‐1) for 10 min)
Number of subjects: 24
Study 20055193 — intervention group
Group type: COMPARATOR
Intervention: Control (no dexmedetomidine)
Number of subjects: 24
Study 16715977 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 100
Study 16715977 — intervention group
Group type: COMPARATOR
Intervention: Minimally-invasive cholecystectomy
Number of subjects: 100
Study 15355582 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 121
Study 15355582 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy
Number of subjects: 121
Study 15355582 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic therapy
Number of subjects: 121
Study 11694026 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 829
Study 11694026 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 829
Study 11694026 — intervention group
Group type: COMPARATOR
Intervention: Nimesulide and Paracetamol
Number of subjects: 829
Study 11694026 — intervention group
Group type: COMPARATOR
Intervention: Chronic Urticaria History
Number of subjects: 829
Study 11694026 — intervention group
Group type: COMPARATOR
Intervention: NSAID-induced Urticaria/Angioedema History
Number of subjects: 829
Study 9389266 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 13
Study 9389266 — intervention group
Group type: COMPARATOR
Intervention: Propofol and alfentanil
Number of subjects: 13
Study 8187303 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment (0.02‐0.05 IU/kg body weight subcutaneously at bedtime)
Number of subjects: 40
Study 8187303 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 40
Study 8187303 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 40
Study 3129593 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐mg daily intravenous injection of vitamin K
Number of subjects: 60
Study 3129593 — intervention group
Group type: EXPERIMENTAL
Intervention: 10‐mg weekly intramuscular injection of vitamin K
Number of subjects: 60
Study 3129593 — intervention group
Group type: COMPARATOR
Intervention: No vitamin K (28 patients from earlier study)
Number of subjects: 60
Study 30655636 — intervention group
Group type: EXPERIMENTAL
Intervention: Deprox® (flower pollen extracts)
Number of subjects: 54
Study 30655636 — intervention group
Group type: COMPARATOR
Intervention: Bioflavonoids (quercetin)
Number of subjects: 54
Study 28460286 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal traumatic exposure
Number of subjects: 378
Study 28460286 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual traumatic exposure
Number of subjects: 378
Study 28460286 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifetime traumatic exposure of mothers
Number of subjects: 378
Study 24583757 — intervention group
Group type: EXPERIMENTAL
Intervention: PUFA (eicosapentaenoic acid 2160 mg and docosahexaenoic acid 1440 mg daily)
Number of subjects: 37
Study 24583757 — intervention group
Group type: COMPARATOR
Intervention: Placebo (isocaloric corn oil)
Number of subjects: 37
Study 22985391 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mL of 2% lidocaine and then 10 mL of 0.75% ropivacaine (Group lr)
Number of subjects: 40
Study 22985391 — intervention group
Group type: COMPARATOR
Intervention: 10 mL of normal saline and then 10 mL of 0.75% ropivacaine (Group r)
Number of subjects: 40
Study 22985391 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mL of 2% lidocaine and then 10 mL of 0.75% ropivacaine (Group LR)
Number of subjects: 40
Study 22985391 — intervention group
Group type: COMPARATOR
Intervention: 10 mL of normal saline and then 10 mL of 0.75% ropivacaine (Group R)
Number of subjects: 40
Study 21330041 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg kg(‐1) adrenaline
Number of subjects: 21
Study 21330041 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 U kg(‐1) vasopressin
Number of subjects: 21
Study 21330041 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 U kg(‐1) vasopressin
Number of subjects: 21
Study 19236498 — intervention group
Group type: EXPERIMENTAL
Intervention: microS+TCD ultrasound (sonolysis)
Number of subjects: 0
Study 19236498 — intervention group
Group type: COMPARATOR
Intervention: saline+brief TCD vessel assessments
Number of subjects: 0